BD, 556419, BD Pharmingen™ FITC Annexin V

Application: Flow cytometry (Routinely Tested)
Vol. Per Test: 5 µl
RRID: AB_2665412
Storage Buffer: Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Regulatory Status: RUO
Preparation And Storage: Preparation And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Recommended Assay Procedures: Recommended Assay Procedures FITC Annexin V is a sensitive probe for identifying apoptotic cells, binding to negatively charged phospholipid surfaces (Kd of ~5 x 10e-2) with a higher affinity for phosphatidylserine (PS) than most other phospholipids. FITC Annexin V binding is calcium dependent and defined calcium and salt concentrations are required for optimal staining as described in the FITC Annexin V Staining Protocol. Investigators should note that FITC Annexin V flow cytometric analysis on adherent cell types (e.g HeLa, NIH 3T3, etc.) is not routinely tested as specific membrane damage may occur during cell detachment or harvesting. Methods for utilizing Annexin V for flow cytometry on adherent cell types, however, have been previously reported (Casiola-Rosen et al . and van Engelend et al.). INDUCTION OF APOPTOSIS USING AN ANTI-HUMAN CD95 (FAS) ANTIBODY The following protocol is provided as an illustration on how FITC Annexin V may be used on a human cell line. Materials 1. A cell line or primary cells that can easily be induced to undergo apoptosis by human Fas mAb. Examples include Daudi lymphoma cells (ATCC CCL-213) and Jurkat T cells (ATCC TIB-152). It is important to note that there can be significant variation between cell lines regarding the level of apoptosis that can be induced through the Fas receptor. Also, not all cell types which express the Fas antigen will necessarily undergo Fas-mediated apoptosis. The cell lines mentioned above are good positive controls as they are strongly induced to undergo apoptosis by Fas mAb. 2.  Anti-human CD95 (Fas) mAb, clone DX2 (Cat. No. 555670). 3.  Recombinant Protein G (Sigma-Aldrich cat.no. P4689). We have found that the addition of Protein G to the tissue culture medium can significantly enhance the efficiency of the DX2 clone to induce apoptosis. 4.  T25 tissue culture flasks. 5.  IMDM or RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS), 1% L-glutamine and 1% antibiotics (penicillin/ streptomycin; 100 U/ml). This supplemented medium is simply referred to as 'medium' below. Procedure 1.  Maintain the cells in culture and change the medium one day before inducing apoptosis. 2.  Induction of apoptosis: Add 0.5 - 2 µg/ml of the anti-CD95 antibody (DX2 clone) and 1-2 µg/ml Protein G to a T25 flask with medium containing ~0.5 × 10e6 cells/ml. Negative controls should consist of: (a) ~0.5 × 10e6 cells/ml with medium alone (no mAb or Protein G), and (b) ~0.5 × 10e6 cells/ml with medium and 1 µg/ml Protein G alone (no mAb). 3. Incubate the cells for 2 to 12 hr at 37°C 4. Proceed with the FITC Annexin V Staining Protocol to measure apoptosis. Apoptosis can also be observed by light microscopy, gel electrophoresis (DNA fragmentation ladders) or by using a DNA fragmentation-based flow cytometry assay system such as the APO-BRDU™ Kit (Cat. No. 556405) or the APO-DIRECT™ Kit (Cat. No. 556381). INDUCTION OF APOPTOSIS USING AN ANTI-MOUSE CD95 (FAS) ANTIBODY The following protocol is provided as an illustration on how FITC Annexin V may be used on murine cells. Materials 1.  A cell line or primary cells that can easily be induced to undergo apoptosis by mouse Fas monoclonal antibody (mAb). Thymocytes isolated from a 4-6 week old BALB/c mouse may be used. 2.  Anti-mouse CD95 (Fas) mAb, clone Jo2 (Cat. No. 554254) 3.  Recombinant Protein G (Sigma-Aldrich cat.no. P4689). We have found that the addition of Protein G to the tissue culture medium can significantly enhance the efficiency of Jo2 mAb to induce apoptosis. 4.  T25 tissue culture flasks 5.  RPMI-1640 medium with 10% heat-inactivated fetal bovine serum (FBS), 1% L-glutamine and 1% antibiotics (penicillin/ streptomycin; 100 U/ml). This supplemented medium is simply referred to as 'medium' below. Procedure 1.  Isolate BALB/c thymocytes from the thymus of a 4-6 week old mouse. 2.  Induction of apoptosis. Add 2.5-10 µg/ml Jo2 (Cat. No. 554254) and 1-2 µg/ml Protein G to a T25 flask containing ~2 × 10e6 thymocytes/ml. Negative controls should consist of (a) ~2 × 10e6  thymocytes/ml with medium alone (no mAb or Protein G) (b) ~2 × 10e6  thymocytes/ml with medium and 1-2 µg/ml Protein G alone (no mAb). 3.  Incubate the cells for 2-12 hrs at 37°C. 4.  Proceed with the FITC Annexin V Staining Protocol to measure apoptosis. Apoptosis can also be observed by light microscopy, gel electrophoresis (DNA fragmentation ladders) or by using a DNA fragmentation-based flow cytometry assay system such as the APO-BRDU™ Kit (Cat. No. 556405) or the APO-DIRECT™ Kit (Cat. No. 556381). FITC ANNEXIN V STAINING PROTOCOL FITC Annexin V is used to quantitatively determine the percentage of cells within a population that are actively undergoing apoptosis. It relies on the property of cells to lose membrane asymmetry in the early phases of apoptosis. In apoptotic cells, the membrane phospholipid phosphatidylserine (PS) is translocated from the inner leaflet of the plasma membrane to the outer leaflet, thereby exposing PS to the external environment.   Annexin V is a calcium-dependent phospholipid-binding protein that has a high affinity for PS, and is useful for identifying apoptotic cells with exposed PS. Propidium Iodide (PI) is a standard flow cytometric viability probe and is used to distinguish viable from nonviable cells. Viable cells with intact membranes exclude PI, whereas the membranes of dead and damaged cells are permeable to PI. Cells that stain positive for FITC Annexin V and negative for PI are undergoing apoptosis. Cells that stain positive for both FITC Annexin V and PI are either in the end stage of apoptosis, are undergoing necrosis, or are already dead. Cells that stain negative for both FITC Annexin V and PI are alive and not undergoing measurable apoptosis. Reagents 1.  FITC Annexin V: Included.  Use 5 µl per test. 2.  Propidium Iodide (PI): Not Included . PI (cat.no. 556463) is a convenient, ready-to-use nucleic acid dye.  Use up to 10 µl per test of a 50 µg/ml solution. 3.  10× Binding Buffer:  Not Included.  0.1 M Hepes (pH 7.4), 1.4 M NaCl, 25 mM CaCl2.  Store at 4°C.  Alternatively, catalog number 556454 may be purchased. Staining 1.  Wash cells twice with cold PBS and then resuspend cells in 1× Binding Buffer at a concentration of 1 × 10e6 cells/ml. 2.  Transfer 100 µl of the solution (1 × 10e5 cells) to a 5 ml culture tube. 3.  Add 5 µl of FITC Annexin V. 4.  Add 10 µl PI.  The optimal concentration of PI may vary among cell lines where 10 µl of a 50 µg/ml stock is most likely the maximum to be required.  Less may yield optimal results in some experimental systems. 5.  Gently vortex the cells and incubate for 15 min at RT (25 °C) in the dark. 6.  Add 400 µl of 1× Binding Buffer to each tube. Analyze by flow cytometry within 1 hr. SUGGESTED CONTROLS FOR SETTING UP FLOW CYTOMETRY The following controls are used to set up compensation and quadrants: 1.  Unstained cells. 2.  Cells stained with FITC Annexin V (no PI). 3.  Cells stained with PI (no FITC Annexin V). Other Staining Controls: A cell line that can be easily induced to undergo apoptosis should be used to obtain positive control staining with FITC Annexin V and/or FITC Annexin V and PI. It is important to note that the basal level of apoptosis and necrosis varies considerably within a population. Thus, even in the absence of induced apoptosis, most cell populations will contain a minor percentage of cells that are positive for apoptosis (FITC Annexin V positive, PI negative or FITC Annexin V positive, PI positive). The untreated population is used to define the basal level of apoptotic and dead cells. The percentage of cells that have been induced to undergo apoptosis is then determined by subtracting the percentage of apoptotic cells in the untreated population from percentage of apoptotic cells in the treated population. Since cell death is the eventual outcome of cells undergoing apoptosis, cells in the late stages of apoptosis will have a damaged membrane and stain positive for PI as well as for FITC Annexin V. Thus the assay does not distinguish between cells that have already undergone an apoptotic cell death and those that have died as a result of necrotic pathway, because in either case the dead cells will stain with both FITC Annexin V and PI.